Intelligent Bio Solutions Inc. (INBS): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$11.44M

Year ended 2026-06-30

2023-06-30 EBITDA (USD) 2026-06-30

Period ended	EBITDA	Change YoY	Source filing
2026-06-30	-$11.44M	n/m	2026-08-19, From 2025-07-01
2025-06-30	-$9.47M	n/m	2026-08-19, From 2024-07-01
2024-06-30	-$9.08M	n/m	2025-08-15, From 2023-07-01
2023-06-30	-$11.63M	n/a	2024-09-18, From 2022-07-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	EBITDA	Change YoY
Intelligent Bio Solutions Inc. (INBS)	2026-06-30	-$11.44M	n/m
Tenon Medical, Inc. (TNON)	2025-12-31	-$12.53M	n/m
Lucid Diagnostics Inc. (LUCD)	2025-12-31	-$48.77M	n/m
Picard Medical, Inc. (PMI)	2025-12-31	-$13.09M	n/m
Cerenome, Inc. (CNSY)	2025-12-31	-$14.85M	n/m
QHSLab, Inc. (USAQ)	2025-12-31	$222.0K	-37.0%
INVO Fertility, Inc. (IVF)	2025-12-31	-$6.56M	n/m
Beyond Air, Inc. (XAIR)	2026-03-31	-$25.94M	n/m
Femasys Inc (FEMY)	2025-12-31	-$17.25M	n/m

Compare INBS, TNON, LUCD, PMI side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗